116 related articles for article (PubMed ID: 17079140)
21. Selective androgen receptor modulators: in pursuit of tissue-selective androgens.
Omwancha J; Brown TR
Curr Opin Investig Drugs; 2006 Oct; 7(10):873-81. PubMed ID: 17086931
[TBL] [Abstract][Full Text] [Related]
22. 7alpha,11beta-Dimethyl-19-nortestosterone: a potent and selective androgen response modulator with prostate-sparing properties.
Cook CE; Kepler JA
Bioorg Med Chem Lett; 2005 Feb; 15(4):1213-6. PubMed ID: 15686944
[TBL] [Abstract][Full Text] [Related]
23. A novel selective androgen receptor modulator, NEP28, is efficacious in muscle and brain without serious side effects on prostate.
Akita K; Harada K; Ichihara J; Takata N; Takahashi Y; Saito K
Eur J Pharmacol; 2013 Nov; 720(1-3):107-14. PubMed ID: 24177288
[TBL] [Abstract][Full Text] [Related]
24. Effect of beta-sitosterol as inhibitor of 5 alpha-reductase in hamster prostate.
Cabeza M; Bratoeff E; Heuze I; Ramírez E; Sánchez M; Flores E
Proc West Pharmacol Soc; 2003; 46():153-5. PubMed ID: 14699915
[No Abstract] [Full Text] [Related]
25. Synthesis and SAR of novel hydantoin derivatives as selective androgen receptor modulators.
Zhang X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2006 Nov; 16(22):5763-6. PubMed ID: 16959487
[TBL] [Abstract][Full Text] [Related]
26. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.
Miner JN; Chang W; Chapman MS; Finn PD; Hong MH; López FJ; Marschke KB; Rosen J; Schrader W; Turner R; van Oeveren A; Viveros H; Zhi L; Negro-Vilar A
Endocrinology; 2007 Jan; 148(1):363-73. PubMed ID: 17023534
[TBL] [Abstract][Full Text] [Related]
27. A novel series of positive modulators of the AMPA receptor: structure-based lead optimization.
Jamieson C; Campbell RA; Cumming IA; Gillen KJ; Gillespie J; Kazemier B; Kiczun M; Lamont Y; Lyons AJ; Maclean JK; Martin F; Moir EM; Morrow JA; Pantling J; Rankovic Z; Smith L
Bioorg Med Chem Lett; 2010 Oct; 20(20):6072-5. PubMed ID: 20817521
[TBL] [Abstract][Full Text] [Related]
28. Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.
Lee SH; Seo HJ; Lee SH; Jung ME; Park JH; Park HJ; Yoo J; Yun H; Na J; Kang SY; Song KS; Kim MA; Chang CH; Kim J; Lee J
J Med Chem; 2008 Nov; 51(22):7216-33. PubMed ID: 18954042
[TBL] [Abstract][Full Text] [Related]
29. Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands.
Shah N; Scanlan TS
Bioorg Med Chem Lett; 2004 Oct; 14(20):5199-203. PubMed ID: 15380227
[TBL] [Abstract][Full Text] [Related]
30. Potent, nonsteroidal selective androgen receptor modulators (SARMs) based on 8H-[1,4]oxazino[2,3-f]quinolin-8-ones.
Higuchi RI; Thompson AW; Chen JH; Caferro TR; Cummings ML; Deckhut CP; Adams ME; Tegley CM; Edwards JP; López FJ; Kallel EA; Karanewsky DS; Schrader WT; Marschke KB; Zhi L
Bioorg Med Chem Lett; 2007 Oct; 17(19):5442-6. PubMed ID: 17703938
[TBL] [Abstract][Full Text] [Related]
31. A novel selective GABA(A) alpha1 receptor agonist displaying sedative and anxiolytic-like properties in rodents.
Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Gratteri P; Besnard F; Costa B; Montali M; Martini C; Fohlin J; De Siena G; Aiello PM
J Med Chem; 2005 Oct; 48(21):6756-60. PubMed ID: 16220991
[TBL] [Abstract][Full Text] [Related]
32. Pyrazolo[1,5-a]pyrimidines as estrogen receptor ligands: defining the orientation of a novel heterocyclic core.
Compton DR; Carlson KE; Katzenellenbogen JA
Bioorg Med Chem Lett; 2004 Nov; 14(22):5681-4. PubMed ID: 15482947
[TBL] [Abstract][Full Text] [Related]
33. Discovery of indole-containing tetracycles as a new scaffold for androgen receptor ligands.
Zhang X; Li X; Allan GF; Musto A; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2006 Jun; 16(12):3233-7. PubMed ID: 16603353
[TBL] [Abstract][Full Text] [Related]
34. The first X-ray crystal structure of the glucocorticoid receptor bound to a non-steroidal agonist.
Madauss KP; Bledsoe RK; Mclay I; Stewart EL; Uings IJ; Weingarten G; Williams SP
Bioorg Med Chem Lett; 2008 Dec; 18(23):6097-9. PubMed ID: 18952422
[TBL] [Abstract][Full Text] [Related]
35. Discovery of 6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)- pyridazinebutanoic acid (FK 838): a novel non-xanthine adenosine A1 receptor antagonist with potent diuretic activity.
Akahane A; Katayama H; Mitsunaga T; Kato T; Kinoshita T; Kita Y; Kusunoki T; Terai T; Yoshida K; Shiokawa Y
J Med Chem; 1999 Mar; 42(5):779-83. PubMed ID: 10072675
[No Abstract] [Full Text] [Related]
36. Structure-Based Approach To Identify 5-[4-Hydroxyphenyl]pyrrole-2-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators.
Unwalla R; Mousseau JJ; Fadeyi OO; Choi C; Parris K; Hu B; Kenney T; Chippari S; McNally C; Vishwanathan K; Kilbourne E; Thompson C; Nagpal S; Wrobel J; Yudt M; Morris CA; Powell D; Gilbert AM; Chekler ELP
J Med Chem; 2017 Jul; 60(14):6451-6457. PubMed ID: 28696695
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring.
Chen J; Hwang DJ; Chung K; Bohl CE; Fisher SJ; Miller DD; Dalton JT
Endocrinology; 2005 Dec; 146(12):5444-54. PubMed ID: 16166218
[TBL] [Abstract][Full Text] [Related]
38. Diaryl substituted pyrazoles as potent CCR2 receptor antagonists.
Pinkerton AB; Huang D; Cube RV; Hutchinson JH; Struthers M; Ayala JM; Vicario PP; Patel SR; Wisniewski T; DeMartino JA; Vernier JM
Bioorg Med Chem Lett; 2007 Feb; 17(3):807-13. PubMed ID: 17088058
[TBL] [Abstract][Full Text] [Related]
39. Syntheses of potent, selective, and orally bioavailable indazole-pyridine series of protein kinase B/Akt inhibitors with reduced hypotension.
Zhu GD; Gandhi VB; Gong J; Thomas S; Woods KW; Song X; Li T; Diebold RB; Luo Y; Liu X; Guan R; Klinghofer V; Johnson EF; Bouska J; Olson A; Marsh KC; Stoll VS; Mamo M; Polakowski J; Campbell TJ; Martin RL; Gintant GA; Penning TD; Li Q; Rosenberg SH; Giranda VL
J Med Chem; 2007 Jun; 50(13):2990-3003. PubMed ID: 17523610
[TBL] [Abstract][Full Text] [Related]
40. Imine derivatives as new potent and selective CB2 cannabinoid receptor agonists with an analgesic action.
Ohta H; Ishizaka T; Tatsuzuki M; Yoshinaga M; Iida I; Yamaguchi T; Tomishima Y; Futaki N; Toda Y; Saito S
Bioorg Med Chem; 2008 Feb; 16(3):1111-24. PubMed ID: 18006322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
